XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows used in operating activities    
Net Loss $ (31,127) $ (17,775)
Adjustments to reconcile net los to net cash used in operating activities:    
Stock-based compensation expense 4,011 1,691
Non-cash operating lease expense 40 37
Net accretion of discount on investments (896) (72)
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (426) (2,644)
Accounts payable 1,009 1,987
Accrued compensation (597) (203)
Accrued liabilities 3,606 679
Operating lease liabilities (40) (37)
Net cash used in operating activities (24,420) (16,337)
Cash flows from investing activities    
Purchase of investments (27,136) (53,984)
Maturities of investments 45,900 28,475
Net cash provided by (used in) investing activities 18,764 (25,509)
Cash flows from financing activities    
Proceeds from issuance of common stock from the "at-the-market" offering, net of commissions and offering expenses 19,050  
Repurchase of early exercised stock options   (11)
Proceeds from issuance of common stock from the initial public offering, net of underwriting discounts, commissions and offering expenses   70,376
Proceeds from issuance of common stock under the ESPP 199  
Net cash provided by financing activities 19,249 70,365
Net increase in cash and cash equivalents 13,593 28,519
Cash and cash equivalents at the beginning of the period 27,219 12,097
Cash and cash equivalents at the end of the period 40,812 40,616
Supplemental disclosure of noncash financing items    
Conversion of redeemable convertible preferred stock into common stock   111,139
Accretion to redemption value and cumulative dividends on preferred stock   1,820
Issuance costs for initial public offering included in accounts payable and accrued liabilities   $ 10
Deferred offering costs included in accounts payable and accrued liabilities $ 450